Sign In
Buy PTCT
$68.68
+0.450 (+0.660%)
At Close: Jun 03, 2026
Eric Pauwels Sells 40,290 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock
04:02am, Sunday, 21'st Dec 2025
PTC Therapeutics, Inc. (NASDAQ: PTCT - Get Free Report) insider Eric Pauwels sold 40,290 shares of PTC Therapeutics stock in a transaction that occurred on Wednesday, December 17th. The stock was sold
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 19'th Dec 2025
WARREN, N.J. , Dec. 19, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Dec. 16, 2025, the company approved non-statutory stock options to purchase an aggregate of
PTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
08:00am, Thursday, 18'th Dec 2025
WARREN, N.J. , Dec. 18, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that CEO Matthew B.
PTC Therapeutics, Inc. (PTCT) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
01:28pm, Thursday, 04'th Dec 2025
PTC Therapeutics, Inc. (PTCT) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
PTC Therapeutics Swings to a Profit on $211 Million in Revenue — Is This Why a Major Fund Just Invested $32 Million?
03:36pm, Wednesday, 03'rd Dec 2025
PTC's turnaround quarter is raising eyebrows-here's why one major investor just doubled down.
PTC Therapeutics, Inc. (PTCT) Discusses Progress in Small Molecule Splicing and Ferroptosis Platforms Transcript
04:53am, Wednesday, 03'rd Dec 2025
PTC Therapeutics, Inc. (PTCT) Discusses Progress in Small Molecule Splicing and Ferroptosis Platforms Transcript
Rare-Disease Biotech PTC Is Surging — And One Fund Just Raised Its Bet. Should You?
05:03pm, Tuesday, 02'nd Dec 2025
PTC's strong third quarter and breakout Sephience launch may help explain why one life-sciences fund is quietly upping its bet.
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Monday, 01'st Dec 2025
WARREN, N.J., Dec. 1, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Nov. 24, 2025 , the company approved non-statutory stock options to purchase an aggregate of 2
Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors
09:00am, Monday, 01'st Dec 2025
PONTE VEDRA, Fla., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome current gaps in anticoag
A PTC Therapeutics (PTCT) Insider Sold 10,000 Shares for $795,000
11:28am, Saturday, 29'th Nov 2025
Emma Reeve recently exercised some PTC Therapeutics stock options and sold the shares immediately. Reeve is an independent board director at PTC Therapeutics.
Sandisk Set to Join S&P 500; Upwork, First Interstate BancSystem, PTC Therapeutics to Join S&P SmallCap 600
06:01pm, Monday, 24'th Nov 2025
NEW YORK , Nov. 24, 2025 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P SmallCap 600: S&P SmallCap 600 constituent Sandisk Corp. (NASD: SNDK) will replace
PTC Therapeutics to Host R&D Day
08:00am, Thursday, 20'th Nov 2025
Event to take place on Dec. 2, 2025 in New York City WARREN, N.J. , Nov. 20, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it will host an R&D Day to discuss its pipe
Bank of New York Mellon Corp Acquires 49,728 Shares of PTC Therapeutics, Inc. $PTCT
03:40am, Wednesday, 19'th Nov 2025
Bank of New York Mellon Corp lifted its stake in PTC Therapeutics, Inc. (NASDAQ: PTCT) by 23.0% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Com
This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here's Why
06:30am, Tuesday, 18'th Nov 2025
New York City-based Armistice Capital sold 1,458,192 shares of PTC Therapeutics for an estimated $30.2 million in the third quarter. At quarter-end, Armistice reporting holding a total of nearly 3.3 m
PTC Therapeutics, Inc. (PTCT) Presents at UBS Global Healthcare Conference 2025 Transcript
06:21pm, Tuesday, 11'th Nov 2025
PTC Therapeutics, Inc. ( PTCT ) UBS Global Healthcare Conference 2025 November 11, 2025 3:30 PM EST Company Participants Matthew Klein - CEO & Director Conference Call Participants Ashwani Verma - UBS
